Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Quevedo
P Ron

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Reproduction, Fertility, and Development|May 24, 2005
Ontogeny and the effects of corticosteroid pretreatment on aquaporin water channels in the ovine cerebral cortexNitin P Ron, John A Kazianis, James F Padbury, et al.
The AAPS Journal|September 4, 2009
Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancerYingjuan Lu, Patrick J Klein, Elaine Westrick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2003
Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical resultsBarry A Siegel, Farrokh Dehdashti, David G Mutch, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Reproduction, Fertility, and Development|May 24, 2005
Ontogeny and the effects of corticosteroid pretreatment on aquaporin water channels in the ovine cerebral cortexNitin P Ron, John A Kazianis, James F Padbury, et al.
The AAPS Journal|September 4, 2009
Strategy to prevent drug-related hypersensitivity in folate-targeted hapten immunotherapy of cancerYingjuan Lu, Patrick J Klein, Elaine Westrick, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 7, 2003
Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical resultsBarry A Siegel, Farrokh Dehdashti, David G Mutch, et al.
Pageof 2